Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.35591 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.83746 | 81 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.64427 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.63689 | 86 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.05576 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.16798 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.18005 | 77 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.64666 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.95022 | 82 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.82132 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.60046 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.02998 | 82 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.6774 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.7385 | 81 |